rs71524353

Variant summary

Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBP6

The NM_006005.3(WFS1):​c.1153G>A​(p.Glu385Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000727 in 1,613,944 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00085 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00071 ( 1 hom. )

Consequence

WFS1
NM_006005.3 missense

Scores

6
7
6

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:6

Conservation

PhyloP100: 9.34
Variant links:
Genes affected
WFS1 (HGNC:12762): (wolframin ER transmembrane glycoprotein) This gene encodes a transmembrane protein, which is located primarily in the endoplasmic reticulum and ubiquitously expressed with highest levels in brain, pancreas, heart, and insulinoma beta-cell lines. Mutations in this gene are associated with Wolfram syndrome, also called DIDMOAD (Diabetes Insipidus, Diabetes Mellitus, Optic Atrophy, and Deafness), an autosomal recessive disorder. The disease affects the brain and central nervous system. Mutations in this gene can also cause autosomal dominant deafness 6 (DFNA6), also known as DFNA14 or DFNA38. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Mar 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -3 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.056906283).
BP6
Variant 4-6300948-G-A is Benign according to our data. Variant chr4-6300948-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 178590.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=5, Uncertain_significance=3}. Variant chr4-6300948-G-A is described in Lovd as [Likely_benign].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
WFS1NM_006005.3 linkuse as main transcriptc.1153G>A p.Glu385Lys missense_variant 8/8 ENST00000226760.5 NP_005996.2
WFS1NM_001145853.1 linkuse as main transcriptc.1153G>A p.Glu385Lys missense_variant 8/8 NP_001139325.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
WFS1ENST00000226760.5 linkuse as main transcriptc.1153G>A p.Glu385Lys missense_variant 8/81 NM_006005.3 ENSP00000226760 P2
ENST00000661896.1 linkuse as main transcriptn.1337+2967C>T intron_variant, non_coding_transcript_variant

Frequencies

GnomAD3 genomes
AF:
0.000848
AC:
129
AN:
152098
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000966
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000916
Gnomad ASJ
AF:
0.00923
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00255
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000676
Gnomad OTH
AF:
0.00192
GnomAD3 exomes
AF:
0.00120
AC:
301
AN:
251472
Hom.:
0
AF XY:
0.00128
AC XY:
174
AN XY:
135914
show subpopulations
Gnomad AFR exome
AF:
0.0000615
Gnomad AMR exome
AF:
0.000723
Gnomad ASJ exome
AF:
0.00427
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00118
Gnomad FIN exome
AF:
0.00296
Gnomad NFE exome
AF:
0.00105
Gnomad OTH exome
AF:
0.00196
GnomAD4 exome
AF:
0.000715
AC:
1045
AN:
1461728
Hom.:
1
Cov.:
99
AF XY:
0.000725
AC XY:
527
AN XY:
727204
show subpopulations
Gnomad4 AFR exome
AF:
0.0000896
Gnomad4 AMR exome
AF:
0.000942
Gnomad4 ASJ exome
AF:
0.00528
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00125
Gnomad4 FIN exome
AF:
0.00285
Gnomad4 NFE exome
AF:
0.000460
Gnomad4 OTH exome
AF:
0.00124
GnomAD4 genome
AF:
0.000847
AC:
129
AN:
152216
Hom.:
0
Cov.:
32
AF XY:
0.000900
AC XY:
67
AN XY:
74406
show subpopulations
Gnomad4 AFR
AF:
0.0000963
Gnomad4 AMR
AF:
0.000915
Gnomad4 ASJ
AF:
0.00923
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.000207
Gnomad4 FIN
AF:
0.00255
Gnomad4 NFE
AF:
0.000676
Gnomad4 OTH
AF:
0.00190
Alfa
AF:
0.000827
Hom.:
0
Bravo
AF:
0.000604
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00105
AC:
9
ExAC
AF:
0.00136
AC:
165
EpiCase
AF:
0.000600
EpiControl
AF:
0.00107

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:6
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:2
Uncertain significance, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenAug 01, 2021- -
Likely benign, criteria provided, single submitterclinical testingGeneDxApr 21, 2021This variant is associated with the following publications: (PMID: 23595122, 24909696, 28432734) -
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 04, 2024- -
not specified Uncertain:1Benign:1
Likely benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineFeb 04, 2015p.Glu385Lys in exon 8 of WFS1: This variant is not expected to have clinical sig nificance because it has been identified in 0.4% (24/6748) of European (Finnish ) chromosomes and 0.2% (113/67706) of European (non-Finnish) chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs7152 4353). Although this variant been reported in the heterozygous state in 3 indivi duals with hearing loss and 1 individual with optic atrophy, the variant did not segregate with hearing loss in 1 affected sibling (Kytovuori 2013, Hakli 2014). Moreover, the p.Glu385Lys variant has been identified by our laboratory in 3 in dividuals with hearing loss, but two individuals had an alternate genetic explan ation for their hearing loss. -
Uncertain significance, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoMay 28, 2014- -
WFS1-Related Spectrum Disorders Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
WFS1-related disorder Benign:1
Likely benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesFeb 03, 2021This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Monogenic diabetes Benign:1
Likely benign, criteria provided, single submitterresearchPersonalized Diabetes Medicine Program, University of Maryland School of MedicineFeb 03, 2016ACMG Criteria: PP3, BS2 (type2diabetesgenetics.org), BP4 -
Autosomal dominant nonsyndromic hearing loss 6 Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.85
BayesDel_addAF
Benign
-0.0055
T
BayesDel_noAF
Pathogenic
0.17
CADD
Uncertain
24
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.31
T;T
Eigen
Uncertain
0.54
Eigen_PC
Uncertain
0.58
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.97
.;D
M_CAP
Pathogenic
0.57
D
MetaRNN
Benign
0.057
T;T
MetaSVM
Uncertain
0.47
D
MutationAssessor
Uncertain
2.8
M;M
MutationTaster
Benign
1.0
D;D
PrimateAI
Uncertain
0.60
T
PROVEAN
Benign
-1.9
N;N
REVEL
Pathogenic
0.77
Sift
Benign
0.077
T;T
Sift4G
Uncertain
0.010
D;D
Polyphen
0.96
D;D
Vest4
0.84
MVP
0.99
ClinPred
0.086
T
GERP RS
4.8
Varity_R
0.32
gMVP
0.94

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs71524353; hg19: chr4-6302675; API